How Long Does It Take to Die From Diabetic Ketoacidosis?

Untreated diabetic ketoacidosis can kill within roughly 24 to 48 hours once severe metabolic derangement sets in, though the timeline varies enormously depending on the person’s age, overall health, and how far the crisis has progressed before intervention. Before insulin therapy existed, DKA was a near-certain death sentence that could take days to a couple of weeks. Today, with hospital treatment, DKA resolves in roughly 13 to 17 hours on average, and most patients survive. But the question of “how long” is inseparable from the question of “what goes wrong,” because DKA does not kill through a single clean mechanism. It sets off a cascade of overlapping crises, and any one of them can become fatal at different speeds.

How Quickly DKA Spirals

DKA typically develops over a period of hours to a day or two, not minutes. It starts when the body cannot get enough insulin to move glucose into cells. Without that fuel pathway, the body switches to burning fat at an unsustainable rate, flooding the blood with acidic byproducts called ketones. Blood sugar climbs, the body tries to flush excess glucose through the kidneys, and that heavy urination causes rapid dehydration. The combination of mounting acid, dehydration, and electrolyte loss creates a spiraling crisis.

In someone with type 1 diabetes who stops taking insulin entirely, early symptoms like excessive thirst, frequent urination, nausea, and fatigue can appear within 12 to 24 hours. If nothing is done, those symptoms escalate over the next several hours into vomiting, abdominal pain, rapid breathing (the body’s attempt to blow off acid), confusion, and eventually loss of consciousness. A child or a thin adult with type 1 diabetes and no insulin reserve can move through these stages faster than a larger adult with type 2 diabetes who still produces some insulin. In children, baseline mental state scores are measurably lower at the time of DKA presentation compared with children presenting without DKA, reflecting how quickly the brain is affected.¹

Once a person reaches severe DKA, defined loosely by very low blood pH, extreme dehydration, and altered consciousness, the window without treatment narrows sharply. At that point, death can follow within hours rather than days, usually from one of a handful of specific complications.

What Actually Kills You in DKA

DKA does not kill through high blood sugar alone. The lethal mechanisms are downstream consequences of the metabolic chaos. Three of the most dangerous are cardiac arrest from electrolyte imbalances, brain swelling, and respiratory failure.

Cardiac Arrest From Potassium Shifts

Potassium is the electrolyte most immediately dangerous in DKA. The acidic blood pushes potassium out of cells and into the bloodstream, so initial blood tests may show normal or even high potassium. But the body’s total potassium stores are depleted from all that urination. When treatment begins and insulin drives potassium back into cells, blood potassium can plummet. A dangerously low potassium level disrupts the heart’s electrical system, causing abnormal rhythms that can progress to cardiac arrest. In pediatric cases, profound potassium drops during treatment have directly caused fatal heart rhythms.² Giving insulin to someone in DKA who already has very low potassium can make the situation worse by driving the remaining potassium further into cells, creating a direct path to fatal heart rhythm disturbances.³

This is one of the cruel paradoxes of DKA: the very treatment that saves your life can kill you if electrolytes are not monitored and replaced aggressively. Cardiac arrest from potassium imbalance can happen within minutes once the heart becomes electrically unstable, so this is the fastest way DKA kills.

Cerebral Edema

Brain swelling is especially feared in children with DKA. It can develop during treatment, often within the first 12 hours, when rapid fluid replacement and changes in blood chemistry cause water to shift into brain tissue. The child may initially seem to be improving and then suddenly deteriorate, becoming confused, unresponsive, or seizing. Cerebral edema is recognized as a severe and potentially fatal complication of DKA, with children at particularly high risk.⁴ Treatment guidelines for DKA explicitly warn against overhydration and excessively rapid changes in blood chemistry because of the cerebral edema risk.⁵

Respiratory Failure

Acute respiratory distress syndrome, or ARDS, is rare in DKA but carries high mortality when it occurs. In ARDS, the lungs fill with fluid and lose the ability to exchange oxygen, requiring mechanical ventilation and sometimes advanced life support. Case reports describe young patients, some with no prior diabetes diagnosis, developing ARDS severe enough to require the most extreme form of breathing support available.⁶ Even children can develop ARDS as a DKA complication, though physicians who recognize it early and manage it aggressively can sometimes pull patients through.⁷

Who Dies From DKA and Why

Not everyone faces the same risk. DKA mortality depends heavily on age, pre-existing health conditions, and what triggered the episode in the first place.

Age is a major dividing line. A large study from a North Indian academic hospital found that older patients with DKA had dramatically worse survival: in-hospital survival was about 48% in elderly patients compared with roughly 79% in younger patients. Age itself was an independent risk factor, and infection as the trigger of DKA carried especially high odds of death.⁸ A separate retrospective study built a predictive model for DKA death and found that being over 55, having severe anemia, or having cardiovascular disease all significantly increased the odds of dying in the hospital.⁹

Beyond age, the presence of other chronic conditions makes a substantial difference. A large retrospective cohort found that patients with high comorbidity burden had over three times the odds of dying in the hospital, and sepsis roughly tripled the odds as well. Having type 2 diabetes (rather than type 1) and obesity were also independently associated with higher mortality.¹⁰ The reason type 2 diabetes carries higher DKA mortality is not that the DKA itself behaves differently, but that type 2 patients who develop DKA tend to be older and sicker at baseline.

For patients whose DKA is severe enough to require intensive care, one UK study reported 30-day mortality of about 8%. But the longer-term picture is sobering: mortality climbed to roughly 18% at one year and 35% at five years.¹¹ That five-year number reflects not just the acute danger but the underlying health fragility of people who end up in the ICU with DKA. Many of these patients had needed mechanical ventilation, blood-pressure support, or dialysis during their DKA episode.¹²

When DKA Happens Without the Typical Warning Signs

One of the less intuitive dangers is that DKA can occur without sky-high blood sugar. Most people associate DKA with readings of 300, 500, or even over 700 mg/dL, and that is common. But a variant called euglycemic DKA produces the same dangerous acid buildup while blood sugar stays below 200 mg/dL. Because the telltale high glucose is absent, emergency physicians may not immediately suspect DKA, delaying the start of treatment.¹³

Euglycemic DKA can affect people with either type 1 or type 2 diabetes. It has been increasingly recognized in patients taking SGLT2 inhibitors, a class of diabetes medication that lowers blood sugar partly by dumping glucose into the urine. The medication masks the hyperglycemia that would normally sound the alarm. This form of DKA is just as dangerous metabolically as the classic kind, and the delay in recognition is itself a mortality risk.¹⁴ If you take an SGLT2 inhibitor and develop nausea, vomiting, rapid breathing, or abdominal pain, it is worth telling the emergency department that DKA is possible even if your glucose reading seems acceptable.

How Treatment Changes the Timeline

With appropriate hospital care, DKA is survivable the vast majority of the time. Treatment revolves around intravenous fluids to reverse dehydration, insulin to shut down ketone production, and aggressive electrolyte replacement. In a study comparing two different intravenous fluid approaches, the median time to DKA resolution ranged from about 13 hours with balanced fluids to about 17 hours with normal saline.¹⁵ Those numbers roughly match other data showing a mean resolution time around 16 hours for DKA in general.¹⁶

That resolution time, roughly half a day to a day, is the window where treatment converts a potentially fatal crisis into a recoverable one. But “resolved” does not mean “out of danger.” Patients still need monitoring for rebound episodes, and as mentioned earlier, the treatment itself creates risks. Clinicians watch blood potassium levels every one to two hours during insulin infusion, and many patients need large amounts of potassium replacement to keep levels safe.

Doctors also monitor markers like blood lactate to gauge how well treatment is working. One study found that the rate at which blood lactate clears during the first two hours after hospital admission is a useful predictor of whether a patient will survive the next 30 days.¹⁷ Patients whose lactate drops quickly tend to do well; those whose lactate stays stubbornly high are more likely to deteriorate. A separate analysis found that combining lactate and albumin levels into a single ratio offered even better predictive ability for 28-day mortality.¹⁸

The Recurring Crisis Problem

One often-overlooked aspect of DKA mortality is that many deaths follow not a single episode but a pattern of repeated crises. Among critically ill DKA patients who survived to hospital discharge, about a third were readmitted within one year. Treatment noncompliance was independently associated with the combined outcome of death or readmission in the following year.¹⁹ Each episode batters the body, and each carries the same acute risks as the first.

The reasons for noncompliance are rarely simple stubbornness. Insulin costs in the United States have driven some patients to ration their supply, eat restrictively, or skip doses entirely, leading to emergency hospitalizations with blood sugars in the 700s.²⁰ A study from the United Arab Emirates found that insulin unaffordability accounted for about 13% of DKA admissions, and underinsured patients used ICU services at significantly higher rates. The researchers calculated that the cost of a single preventable DKA hospitalization equaled roughly 27 years of insulin therapy.²¹ That arithmetic is striking: a few dollars of prevention weighed against thousands of dollars and a real risk of death in the hospital.

For people who cannot reliably afford or access insulin, the timeline question is less academic. They may live in a cycle of partial insulin use, creeping ketoacidosis, emergency treatment, discharge, and repeat. Each cycle carries the same acute lethality described above, and the cumulative toll on organs, especially the heart and kidneys, makes each subsequent episode more dangerous than the last.

DKA in Pets

If you are reading this because a pet has been diagnosed with DKA, the physiology is remarkably similar. Dogs and cats with diabetes can develop ketoacidosis that follows the same general trajectory: dehydration, acidosis, electrolyte derangement, and organ failure. In a study comparing insulin protocols for cats and dogs with DKA, all cats that died did so within 78 hours and none had achieved resolution of their ketosis before death. Among dogs, 30% did not survive to discharge, though all had resolved their ketosis before dying, suggesting that in dogs, the organ damage already sustained was the main problem rather than ongoing acid production.²²

The 78-hour window for fatal outcomes in cats provides a rough benchmark: even with veterinary treatment, a severely ill animal that does not begin responding within the first few days faces poor odds. Cats appear particularly vulnerable because they often present later in the course and because their smaller body mass means less physiological reserve to absorb the metabolic insult.